Articles | EuroIntervention

10.4244/EIJV12I3A68 • Jun 20, 2016

Confounding and effect measure modification: analysing sex in cardiovascular research

Kavousi M

free

10.4244/EIJV12I3A69 • Jun 20, 2016

How should I treat a patient with a mechanical aortic valve prosthesis and recurrent intracranial bleeding on anticoagulation with a patent LIMA to LAD?

Patterson T, Davies W, Rajani R, Redwood S, Young C, Thomas M, Bosmans J, Rodrigus I, Melnitchouk S, Sundt T

free

10.4244/EIJV12I3A70 • Jun 20, 2016

Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort

Rigamonti F, Banfi C, Roffi M, Giraud R

free

10.4244/EIJV12I3A71 • Jun 20, 2016

Long-term prognosis after extracorporeal life support in refractory cardiogenic shock – results from a real-world cohort

de Waha S, Fuernau G, Eitel I, Desch S, Thiele H

free

10.4244/EIJV12I3A49 • Jun 20, 2016

EAPCI, a new team, but the same commitment!

Haude M

free

10.4244/EIJV12I2A23 • Jun 10, 2016

Looking into the publishing orbuculum: the year 2020

Cummins P, Serruys PW

free

10.4244/EIJV12I2A24 • Jun 10, 2016

The current status of endovascular treatment for acute ischaemic stroke

Kilic D, Goktekin O

free

10.4244/EIJV12I2A25 • Jun 10, 2016

PCR Innovators Day: dreaming with our eyes wide open…

Wijns W, Cassak D, Levin S

free

• Jun 10, 2016

EAPCI “Focus on a Fellow”, the EAPCI Fellowship Experience

free

CLINICAL RESEARCH

10.4244/EIJY16M05_03 • Jun 10, 2016

Impact of stent size on angiographic and clinical outcomes after implantation of everolimus-eluting bioresorbable scaffolds in daily practice: insights from the ISAR-ABSORB registry

Wiebe J, Hoppmann P, Kufner S, Harada Y, Colleran R, Michel J, Giacoppo D, Schneider S, Cassese S, Ibrahim T, Schunkert H, Laugwitz K, Kastrati A, Byrne RA

free

CLINICAL RESEARCH

10.4244/EIJV12I2A27 • Jun 10, 2016

Percutaneous coronary intervention for chronic total occlusion of the coronary artery with the implantation of bioresorbable everolimus-eluting scaffolds. Poznan CTO-Absorb Pilot Registry

Lesiak M, Łanocha M, Araszkiewicz A, Siniawski A, Grygier M, Pyda M, Olasińska-Wiśniewska A, Iwanczyk S, Skorupski W, Mitkowski P, Lesiak M, Grajek S

free

CLINICAL RESEARCH

10.4244/EIJV12I2A28 • Jun 10, 2016

One-year outcomes after Absorb bioresorbable vascular scaffold implantation in routine clinical practice

Capranzano P, Longo G, Tamburino Cl, Gargiulo G, Ohno Y, Francaviglia B, La Manna A, Di Salvo M-E, Grasso C, Sgroi C, Capodanno D, Tamburino C

free

CLINICAL RESEARCH

10.4244/EIJ-D-15-00371 • Jun 10, 2016

Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial

Haude M, Erbel R, Erne P, Verheye S, Degen H, Vermeersch P, Weissman N, Prati F, Bruining N, Waksman R, Koolen J

free

CLINICAL RESEARCH

10.4244/EIJV12I2A30 • Jun 10, 2016

Bioresorbable polymer sirolimus-eluting coronary stent compared with permanent polymer everolimus-eluting coronary stent implantation for treatment of small vessel coronary artery disease: CENTURY II trial

Wöhrle J, Markovic S, Rottbauer W, Muramatsu T, Kadota K, Vázquez-González N, Odenstedt J, Serra A, Antoniucci D, Varenne O, Saito S, Wijns W

free

CLINICAL RESEARCH

10.4244/EIJ-D-15-00542 • Jun 10, 2016

Comparison of clinical outcomes between bioresorbable vascular stents versus conventional drug-eluting and metallic stents: a systematic review and meta-analysis

Banach M, Serban M-C, Sahebkar A, Garcia-Garcia H, Mikhailidis D, Martin S, Brie D, Rysz J, Toth P, Jones S, Hasan R, Mosteoru S, Rifai M, Pencina M, Serruys PW

free